ViengKham logo
Home About Us Innovation Manufacturing Quality & Compliance Products News Contact
English 中文 ລາວ
Terms of Use
← Home

ViengKham Pharmaceutical Co., Ltd

Terms of Use

Terms governing use of the ViengKham website and its published information.

Terms of Use

By accessing this website, you agree to use the information responsibly and in accordance with applicable laws and regulations.

Website Information

The information on this website is provided for corporate introduction, product registration, business communication, and general informational purposes. It does not constitute medical advice, diagnosis, treatment recommendation, investment advice, or product promotion in any market where regulatory approval has not been granted.

Product Information

Product availability, registration status, indications, labeling, and supply conditions may vary by country or region. Users should rely on approved local labels, professional medical judgment, and applicable regulatory requirements.

Intellectual Property

Text, images, logos, page design, and other content on this website belong to or are used by ViengKham Pharmaceutical Co., Ltd unless otherwise stated. Unauthorized commercial use is not permitted.

Changes

ViengKham may update website content or these Terms of Use from time to time. Continued use of the website means acceptance of the updated terms.

Updated: 2026-06-14 13:03:09

ViengKham logo

Consistency is Our Innovation.

Advancing health through innovation and care.

Products

Lorlatinib Orforglipron Tirzepatide Capmatinib Lenacapavir Semaglutide

Contact

info@viengkham.com +856 20 92329383 No. 2, Viengkham Village, Vientiane Province, Lao PDR
Privacy Policy Terms of Use

Information on this website is intended for corporate, product registration and business communication purposes only. It does not constitute medical advice, diagnosis, treatment recommendation or product promotion in markets where regulatory approval has not been granted.

© 2026 ViengKham Pharmaceutical Co., Ltd. All rights reserved.